/STE
STERIS plc
STE • NYSESTE • NYSE • Healthcare
$243.07-0.12%-0.28
$243.07-0.12%(-0.28)Healthcare
GoAI Score
Sign in to unlock
Valuation
50Fair Value
Sentiment
55Neutral
Risk
79Low Risk
Momentum
40Neutral
Institutional-Grade Intelligence
🏆PRO
Actionable Intelligence
AI-driven stance, execution logic & risk thresholds
Catalyst Roadmap
Event timeline with expected impact & market context
Deep Insights
Fact-checked analysis & score logic breakdown
Financial Statements
Margin Trends
Gross
44.0%▲0.8pp
Revenue after COGS
Operating
15.9%▼0.4pp
After operating expenses
Net
11.3%▲3.9pp
Bottom-line profitability
Gross Margin
Operating Margin
Net Margin
Valuation Snapshot
P/E Ratio
36.3
Price vs earnings
EV/EBITDA
17.9
Enterprise value
FCF Yield
3.5%
Cash generation
Earnings Yield
2.8%
Inverse of P/E
Capital Efficiency
8
GoAI Quality ScoreWeak
ROEReturn on Equity
9.3%Fair
ROAReturn on Assets
6.1%Strong
ROICReturn on Invested Capital
7.2%Fair
Financial Health
Current RatioHealthy
1.96
Short-term solvency (>1.5)
Net Debt / EBITDAManageable
1.49x
Debt repayment capacity (<3x)
Income QualityStrong
1.86
Cash backs earnings (>1)
Revenue & Profitability
Revenue
Net Income
Net Loss
Income Statement
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $5.46B | $5.14B | $4.54B | $4.22B | $3.11B |
| Gross Profit | $2.40B | $2.22B | $1.98B | $1.88B | $1.34B |
| Gross Margin | 44.0% | 43.2% | 43.7% | 44.6% | 43.2% |
| Operating Income | $866.64M | $836.12M | $791.10M | $477.81M | $548.37M |
| Net Income | $614.64M | $378.24M | $107.03M | $243.89M | $397.40M |
| Net Margin | 11.3% | 7.4% | 2.4% | 5.8% | 12.8% |
| EPS | $6.24 | $3.83 | $1.07 | $2.50 | $4.66 |
Average Price Target
$256.67▲ 5.6% Upside
Past 12 Months
12 Month Forecast
Based on 50 Wall Street analysts offering 12 month price targets for STERIS plc, the average price target is $256.67, with a high forecast of $265.00 and a low forecast of $245.00. The average price target represents a 5.6% increase from the current price of $243.07.
Highest
$265.00
Average
$256.67
Lowest
$245.00
Rating Distribution
Strong Buy
0
0%
Buy
11
85%
Hold
2
15%
Sell
0
0%
Strong Sell
0
0%
Recent Analyst Ratings
FirmActionRatingDate
Morgan Stanley● Maintain
Overweight
2025-08-08Keybanc● Maintain
Overweight
2025-07-22Morgan Stanley▲ Upgrade
Equal Weight→Overweight
2025-07-15Morgan Stanley● Maintain
Equal Weight
2025-05-19JMP Securities● Maintain
Market Outperform
2025-05-16Stephens & Co.● Maintain
Overweight
2025-05-15Morgan Stanley● Maintain
Equal Weight
2025-05-12JMP Securities● Maintain
Market Outperform
2025-04-10Needham● Maintain
Hold
2025-04-07JMP Securities● Maintain
Market Outperform
2025-02-06Earnings History & Surprises
BEAT RATE
67%
Last 18 quarters
AVG SURPRISE
+2.5%
EPS vs Estimate
BEATS / MISSES
12/4
2 met exactly
LATEST EPS
$2.53
Q1 '26
QUARTERLY EPS TREND
Estimated
Beat
Miss
QUARTERLY DETAIL
Q1 '26
$2.53 vs $2.53
Q4 '25
+5.1%
$2.47 vs $2.35
Q3 '25
+3.5%
$2.34 vs $2.26
Q2 '25
+5.4%
$2.74 vs $2.60
Q1 '25
-0.4%
$2.32 vs $2.33
Q4 '24
+0.9%
$2.14 vs $2.12
Q3 '24
+2.5%
$2.03 vs $1.98
Q2 '24
+2.6%
$2.41 vs $2.35
Q1 '24
+2.3%
$2.22 vs $2.17
Q4 '23
-1.0%
$2.03 vs $2.05
Q3 '23
+7.5%
$2.00 vs $1.86
Q2 '23
+7.0%
$2.30 vs $2.15
No investor questions available.
Latest News
No news available